Respiratory distress syndrome – Page 10 – Communicable Diseases Research

Selective Lobe Ventilation and a Novel Platform for Pulmonary Drug Delivery

선택적 엽 환기 및 폐 약물 전달을위한 새로운 플랫폼

Review

Published on 2021-11-012022-08-31
Journal: Journal of cardiothoracic and vascular anesthesia [Category] MERS, SARS, 치료제,

COVID-19: Impact on radiology departments and implications for future service design, service delivery, and radiology education

COVID-19 : 방사선과에 미치는 영향 및 향후 서비스 설계, 서비스 제공 및 방사선 교육에 대한 영향

Review

Published on 2021-11-012022-09-10
Journal: The British Journal of Radiology [Category] 치료기술,

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism

GDF15: 철 대사와 관련된 COVID-19의 면역 조절제 및 전략

Review

Published on 2021-11-012022-09-11
Journal: Trends in endocrinology and metabolism: TEM [Category] Coronavirus, SARS, 바이오마커, 신약개발, 치료법,

[키워드] ACE2 acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus alteration angiotensin appear association attachment cardiovascular diseases caused contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Critically ill Cytokine storm death domain drug therapy ENCODE endothelial envelope enzyme expressed GDF15 growth host cell host cells Immunity increases in iron iron homeostasis Iron metabolism life cycle mediator membrane metabolism multiorgan failure nucleocapsid outcome pandemic Patient patients with COVID-19 progression of disease Proteins provide Receptor-binding domain respiratory distress Respiratory distress syndrome responsible SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 structural protein structural proteins subunit syndrome target TGF-β therapeutic therapy tissue tissue damage Tolerance transforming growth factor vascular dysfunction virus Virus life cycle with COVID-19
[DOI] 10.1016/j.tem.2021.08.011 PMC 바로가기 [Article Type] Review

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19

경증에서 중증 COVID-19를 구별하기 위한 바이오마커로서의 항인지질 항체 및 칼프로텍틴의 평가

Article

Published on 2021-11-012022-09-11
Journal: Journal of Clinical Laboratory Analysis [Category] MERS, SARS, 바이오마커, 진단, 치료기술,

[키워드] acute respiratory distress acute respiratory distress syndrome antibodies antibody anticardiolipin antibodies anticardiolipin antibody antiphospholipid antibodies assessment association Biomarker C-reactive protein C-reactive protein (CRP calprotectin CD4 clinically coronavirus coronavirus disease correlation COVID-19 COVID-19 patient COVID-19 patients CRP CRP level CRP levels detectable Detection limit elevated ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated ferritin groups healthy control healthy controls help highest Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients IgM immunoassay IMPROVE Inflammatory laboratory parameter lymphocyte Lymphocyte count management Mild moderate multiplex negative correlation neutrophil Neutrophil-to-lymphocyte ratio no significant differences not differ outcome oxygenation status parameter pathway peak levels Prevalence procalcitonin proportion respiratory distress Respiratory distress syndrome sera severe COVID-19 severe group severity significant differences significantly significantly higher syndrome T cells two group two groups were measured
[DOI] 10.1002/jcla.24004 PMC 바로가기 [Article Type] Article

Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital

인도네시아 국립 위탁 병원에서 D-dimer, 염증 표지자 및 COVID-19 중증도 사이의 응고 프로파일 및 상관 관계

Article

Published on 2021-11-012022-09-11
Journal: The Journal of international medical research [Category] MERS, SARS, 바이오마커,

[키워드] 95% confidence interval Accuracy acute respiratory distress acute respiratory distress syndrome Admission ARDS AUC C-reactive protein can be used characteristic Coagulopathy Combination Concentration coronavirus coronavirus disease Coronavirus disease 2019 correlation COVID-19 COVID-19 cases COVID-19 severity cross-sectional study CRP cutoff value D-dimer D-dimer value dimer disease evaluated ferritin Health Organization highest hospital Inflammation Inflammatory marker inflammatory markers marker median Mild moderate National on admission receiver receiver operating characteristic respiratory distress Respiratory distress syndrome Retrospective cross-sectional study severe ARDS severity Severity of infection syndrome WHO World Health Organization
[DOI] 10.1177/03000605211059939 PMC 바로가기 [Article Type] Article

Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis

2019년 코로나바이러스감염증(Covid-19)과 관련된 임상 및 실험실 요인: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-11-012022-09-11
Journal: Reviews in Medical Virology [Category] SARS, 치료제,

[키워드] acute respiratory distress acute respiratory distress syndrome age ARDS Bilateral clinical clinical presentation Comorbidity Complete Complication Confident confirmed case coronavirus disease COVID-19 COVID-19 patients criteria Critical death death group diabete diabetes disease Evidence Factor Follow-up form ground-glass opacification group groups highest hypertension Laboratory meta-analysed Meta-analysis Mild mortality rate mortality rates non-survivor Non-survivors Patient performed Pneumonia Prognosis proportion radiological radiology remained respiratory distress Respiratory distress syndrome SARS Coronavirus SARS-CoV-2 severe pneumonia severity smoking Symptomatology symptomatology. Symptoms syndrome systematic review Treatment virus while widespread
[DOI] 10.1002/rmv.2288 PMC 바로가기 [Article Type] Meta-Analysis

Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma

고역가 회복기 혈장으로 치료한 SARS-CoV-2 폐렴 환자의 말초혈액 내 사이토카인 및 케모카인 상승

Research Article

Published on 2021-10-292022-09-12
Journal: PLoS Pathogens [Category] MERS, SARS, 진단,

[키워드] acute respiratory distress acute respiratory distress syndrome addition administration Blood caused chemokine chemokines Clinical course clinical trial Cohort Concentration conducted contribute convalescent convalescent plasma Convalescent plasma therapy correlated Course COVID-19 COVID-19 pneumonia CRP cytokine Cytokine storm syndrome Cytokines Day Deterioration Disease progression Donor donors Efficacy elevated Elevation elevations evaluate fatality foundation healthy controls Hospitalization Hospitalized hospitalized COVID-19 hospitalized COVID-19 patient hospitalized COVID-19 patients IIa immune immune activation immune response IMPROVE increase in Inflammatory Inflammatory cytokines infusion institution Lung pathology mechanical ventilation MIP-1α MIP-1β Neutralizing antibodies neutralizing antibody Neutralizing titer observation outcomes pandemic Patient patients patients hospitalized patients with SARS-CoV-2 Peripheral blood phase plasma plasma sample plasma samples Pneumonia Potential biomarker potential biomarkers receive recipient recipients respiratory distress Respiratory distress syndrome resulting SARS-CoV-2 coronavirus SARS-COV-2 infection SARS-CoV-2 virus significant difference syndrome the cytokine storm the disease the patient the SARS-CoV-2 virus the timing track transfer treat treated Treatment unique virus while with COVID-19
[DOI] 10.1371/journal.ppat.1010025 PMC 바로가기 [Article Type] Research Article

Intubated COVID-19 predictive (ICOP) score for early mortality after intubation in patients with COVID-19

Article

Published on 2021-10-262022-10-04
Journal: Scientific Reports [Category] MERS, 치료법,

Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2)

혁신적인 임상 시험 설계 및 전달: 전문 간호 및 생활 보조 시설(BLAZE-2)에서 COVID-19 노출 후 예방 연구 3상

Randomized Controlled Trial

Published on 2021-10-212022-09-10
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addressed all age groups allergy analytics bamlanivimab BLAZE-2 Care Clinical trial design collaboration Community complications conducted Conducting coronavirus coronavirus disease coronavirus disease-2019 COVID-19 Critical case defined double-blind Efficacy and safety evaluate home care Infectious diseases Lilly LY3819253 monoclonal antibody morbidity morbidity and mortality nursing home Older Older adults pandemic participant Phase 3 Placebo placebo-controlled trial populations Prevalence Prevent Prophylaxis Pulmonary infection randomization Randomized Research respiratory respiratory distress Respiratory distress syndrome Respiratory failure risk SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe and critical cases severe COVID-19 Skilled nursing facilities Spread spread of COVID-19 supplementary material Supply chain Support symptomatic infection syndrome target population Therapeutic strategies therapeutic strategy Travel Trial USA
[DOI] 10.1186/s13063-021-05699-3 PMC 바로가기 [Article Type] Randomized Controlled Trial

Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial

COVID-19 폐렴 및 중등도에서 중증 ARDS 환자에서 체외 순환이 없는 초저 일회 호흡 호흡의 공개 라벨 무작위 대조 시험: VT4COVID 시험을 위한 연구 프로토콜

Study Protocol

Published on 2021-10-112022-09-10
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] 1:1 acute respiratory distress syndrome Adult patient Adult patients all-cause mortality Analysis analyzed ARDS block body weight circulation complication of COVID-19 consumables control group COVID-19 COVID-19 pneumonia criterion data-driven defined distress eligible extracorporeal circulation groups Inclusion intensive care intensive care unit intention-to-treat intervention group Invasive mechanical ventilation less Lung injury manuscript mechanical ventilation Mild moderate Mortality mortality rate outcomes PaO Patient patients with COVID-19 Pneumonia predicted Prevent Primary outcome Protective random randomization list Randomized Randomized controlled trial recruitment reduce respiratory distress Respiratory distress syndrome SARS-CoV-2 selective severe ARDS stratified Study protocol supplementary material syndrome Tidal volume Transparency treat Trial Trial registration Ultra-low tidal volume ventilation Ultraprotective ventilation Ventilated Ventilation ventilator ventilator-free day Ventilator-free days Volume worldwide pandemic
[DOI] 10.1186/s13063-021-05665-z PMC 바로가기 [Article Type] Study Protocol